NO20006312D0 - Terapeutiske blandinger av selektive östrogenreseptor- modulatorer (SERM) og veksthormon sekretstimulerende middel (GHS) for behandling av muskuloskjelett skjörhet - Google Patents

Terapeutiske blandinger av selektive östrogenreseptor- modulatorer (SERM) og veksthormon sekretstimulerende middel (GHS) for behandling av muskuloskjelett skjörhet

Info

Publication number
NO20006312D0
NO20006312D0 NO20006312A NO20006312A NO20006312D0 NO 20006312 D0 NO20006312 D0 NO 20006312D0 NO 20006312 A NO20006312 A NO 20006312A NO 20006312 A NO20006312 A NO 20006312A NO 20006312 D0 NO20006312 D0 NO 20006312D0
Authority
NO
Norway
Prior art keywords
ghs
serm
treatment
growth hormone
estrogen receptor
Prior art date
Application number
NO20006312A
Other languages
English (en)
Norwegian (no)
Other versions
NO20006312L (no
Inventor
Hua Zhu Ke
Lei Li
Lydia Codetta Pan
David Duane Thompson
Original Assignee
Pfizer Prod Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pfizer Prod Inc filed Critical Pfizer Prod Inc
Publication of NO20006312L publication Critical patent/NO20006312L/no
Publication of NO20006312D0 publication Critical patent/NO20006312D0/no

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/02—Stomatological preparations, e.g. drugs for caries, aphtae, periodontitis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/08—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/08—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
    • A61P19/10—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease for osteoporosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Physical Education & Sports Medicine (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Rheumatology (AREA)
  • Epidemiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
NO20006312A 1998-06-16 2000-12-12 Terapeutiske blandinger av selektive östrogenreseptor- modulatorer (SERM) og veksthormon sekretstimulerende middel (GHS) for behandling av muskuloskjelett skjörhet NO20006312D0 (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US8946998P 1998-06-16 1998-06-16
PCT/IB1999/001117 WO1999065486A1 (en) 1998-06-16 1999-06-16 Therapeutic combinations of (selective) estrogen receptor modulators (serm) and growth hormone secretagogues (ghs) for treating musculoskeletal frailty

Publications (2)

Publication Number Publication Date
NO20006312L NO20006312L (no) 2000-12-12
NO20006312D0 true NO20006312D0 (no) 2000-12-12

Family

ID=22217825

Family Applications (1)

Application Number Title Priority Date Filing Date
NO20006312A NO20006312D0 (no) 1998-06-16 2000-12-12 Terapeutiske blandinger av selektive östrogenreseptor- modulatorer (SERM) og veksthormon sekretstimulerende middel (GHS) for behandling av muskuloskjelett skjörhet

Country Status (30)

Country Link
EP (1) EP1087764A1 (is)
JP (1) JP2002518326A (is)
KR (1) KR20010052852A (is)
CN (1) CN1301160A (is)
AP (1) AP9901582A0 (is)
AR (1) AR018869A1 (is)
AU (1) AU4054799A (is)
BG (1) BG105041A (is)
BR (1) BR9911324A (is)
CA (1) CA2335134A1 (is)
CO (1) CO5070587A1 (is)
EA (1) EA200001186A1 (is)
GT (1) GT199900087A (is)
HN (1) HN1999000097A (is)
HR (1) HRP20000859A2 (is)
HU (1) HUP0102505A3 (is)
ID (1) ID27599A (is)
IL (1) IL138630A0 (is)
IS (1) IS5691A (is)
MA (1) MA26652A1 (is)
NO (1) NO20006312D0 (is)
OA (1) OA11505A (is)
PA (1) PA8475901A1 (is)
PE (1) PE20000646A1 (is)
PL (1) PL344981A1 (is)
SK (1) SK18912000A3 (is)
TN (1) TNSN99124A1 (is)
TR (1) TR200003544T2 (is)
WO (1) WO1999065486A1 (is)
ZA (1) ZA993975B (is)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2000047735A2 (en) * 1999-02-08 2000-08-17 Mcgill University NON-HUMAN TRANSGENIC ANIMAL WHOSE GERM CELLS AND SOMATIC CELLS CONTAIN A KNOCKOUT MUTATION IN DNA ENCODING ORPHAN NUCLEAR RECEPTOR ERRalpha
ES2274854T3 (es) 2000-05-08 2007-06-01 Pfizer Products Inc. Resolucion enzimatica de moduladores selectivos del receptor de estrogeno.
IL145106A0 (en) * 2000-08-30 2002-06-30 Pfizer Prod Inc Intermittent administration of a geowth hormone secretagogue
MXPA03001771A (es) * 2000-08-30 2003-06-04 Pfizer Prod Inc Formulaciones de liberacion sostenida para secretagogos de hormona del crecimiento.
US7476653B2 (en) 2003-06-18 2009-01-13 Tranzyme Pharma, Inc. Macrocyclic modulators of the ghrelin receptor
WO2006024931A2 (en) * 2004-08-31 2006-03-09 Pfizer Products Inc. Therapeutic combinations comprising a selective estrogen receptor modulator and a selective androgen receptor modulator
CU23558A1 (es) 2006-02-28 2010-07-20 Ct Ingenieria Genetica Biotech Compuestos análogos a los secretagogos peptidicos de la hormona de crecimiento
CA2677399C (en) 2007-02-09 2016-09-13 Tranzyme Pharma, Inc. Macrocyclic ghrelin receptor modulators and methods of using the same

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
UA51676C2 (uk) * 1995-11-02 2002-12-16 Пфайзер Інк. (-)цис-6(s)-феніл-5(r)[4-(2-піролідин-1-ілетокси)феніл]-5,6,7,8-тетрагідронафталін-2-ол d-тартрат, спосіб його одержання, спосіб лікування захворювань, що піддаються лікуванню агоністами естрогену, та фармацевтична композиція
TW432073B (en) * 1995-12-28 2001-05-01 Pfizer Pyrazolopyridine compounds
HN1996000101A (es) * 1996-02-28 1997-06-26 Inc Pfizer Terapia combinada para la osteoporosis

Also Published As

Publication number Publication date
PA8475901A1 (es) 2000-05-24
PE20000646A1 (es) 2000-08-05
IS5691A (is) 2000-10-27
ID27599A (id) 2001-04-12
HN1999000097A (es) 1999-11-03
BG105041A (en) 2001-08-31
HRP20000859A2 (en) 2001-04-30
BR9911324A (pt) 2001-04-03
CA2335134A1 (en) 1999-12-23
WO1999065486A1 (en) 1999-12-23
TNSN99124A1 (fr) 2005-11-10
KR20010052852A (ko) 2001-06-25
AU4054799A (en) 2000-01-05
SK18912000A3 (sk) 2001-10-08
EA200001186A1 (ru) 2001-06-25
EP1087764A1 (en) 2001-04-04
AP9901582A0 (en) 1999-06-30
AR018869A1 (es) 2001-12-12
HUP0102505A3 (en) 2002-12-28
OA11505A (en) 2004-05-07
ZA993975B (en) 2000-12-15
NO20006312L (no) 2000-12-12
CO5070587A1 (es) 2001-08-28
TR200003544T2 (tr) 2001-04-20
PL344981A1 (en) 2001-11-19
HUP0102505A2 (hu) 2001-11-28
IL138630A0 (en) 2001-10-31
MA26652A1 (fr) 2004-12-20
JP2002518326A (ja) 2002-06-25
CN1301160A (zh) 2001-06-27
GT199900087A (es) 2000-12-07

Similar Documents

Publication Publication Date Title
DK0991372T3 (da) Apparat til dermatologisk behandling
DE60138129D1 (de) Apparat zur behandlung von zähnen
DK0985697T3 (da) Oxiranderivater og fremgangsmåde til fremstilling deraf
NO20004098D0 (no) FremgangsmÕter og preparater for behandling av makrofag- formidlede lidelser
NO985360D0 (no) FremgangsmÕte og apparat for human avliving av fisk
DE69731515D1 (de) Gerät zur Behandlung fotoempfindlichen Materials
NO20030668D0 (no) Apparat og metode for telemetri
IS4805A (is) Aðferð til meðhöndlunar og lyfjasamsetning
EE200100053A (et) Biogeensete östrogeensulfamaatide kasutamine hormoonasendusraviks
DK0994706T3 (da) Præparater til oral indgivelse af taxaner og anvendelse deraf
NO995034D0 (no) Tannimplantatsystem og fremgangsmåte for dettes fremstilling
DK1003383T3 (da) Smagsforstærkende N-ethyl-p-menthan-3-carboxamidindeholdende forbindelser og fremgangsmåde til fremstilling og anvendelse deraf
DK1131083T3 (da) Anvendelse af væksthormonfrigørende forbindelser og antagonister deraf til behandling af tumorer
DK573189A (da) Fremgangsmaade og apparat til behandling af affaldsmateriale
NO20011824D0 (no) Gjödningsblandinger med kontrollert frigjöring og fremgangsmåter for fremstilling derav
DK205890A (da) Fremgangsmaade og apparat til findeling af massegodsmateriale
NO20006381D0 (no) Terapeutiske kombinasjoner av (selektive) östrogenreseptormodulatorer (SERM) og veksthormonsekresjonsmidler
NO20021947D0 (no) Bio-b¶rende matrikser, fremgangsmåte for fremstilling og anvendelse derav
IS5691A (is) Meðferðarsamsetningar af (valvísum) estrógen viðtaka beinum (SERM) og vaxtarhormóns seytum (GHS) til meðhöndlunar á veikleika í beinagrindarvöðva
NO20010773D0 (no) Fremgangsmåte for kvalitetskontroll av börstehår og anvendelse av slike börstehår
DK1031565T3 (da) Hidtil ukendte krystaller af depsipeptidderivat og fremgangsmåde til fremstilling heraf
DK1042036T3 (da) Fremgangsmåde og apparat til affaldsbehandling
DK0891703T3 (da) Indretning til forberedelse og fordeling af foder til kvæg
NO20022990D0 (no) Fremgangsmåte og sammensetning for behandling av smerte
NO962782D0 (no) Farmasöytiske formuleringer omfattende polytiourea, og metode for anvendelse derav

Legal Events

Date Code Title Description
FC2A Withdrawal, rejection or dismissal of laid open patent application